Sana Biotechnology (SANA)
(Delayed Data from NSDQ)
$3.09 USD
-0.20 (-6.08%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.11 +0.02 (0.65%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SANA 3.09 -0.20(-6.08%)
Will SANA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SANA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SANA
SANA Gears Up to Report Q4 Earnings: What's in the Cards?
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data
SANA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Sana (SANA) Could be Great Choice for a Bottom Fisher
Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround
Other News for SANA
SANA Crossed Above 20 Day Moving Average on September 18
Is SANA setting up for a drop? 20 Day Moving Average Resistance shows up after slipping 1.94%
H.C. Wainwright Sticks to Their Buy Rating for Sana Biotechnology (SANA)
Is SANA primed for downward momentum? Fell Below 20 Day Moving Average shows up after sinking 4.02%
SANA forms 20 Day Moving Average Support on September 15